Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Physical and in Vitro Release Properties of Methylcellulose-Based Thermo-Sensitive Hydrogels

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Influence of Sodium Alginate on the Properties of Methylcellulose-Based Thermo-Sensitive Hydrogels

Thermosensitive hydrogel based on poly(ether-ester anhydride) nanoparticle as drug delivery system: preparation, characterization and biocompatibility.

In Vitro Evaluation of Lysozyme-loaded Microspheres in Thermosensitive Methylcellulose-based Hydrogel

Preparation and Properties of Crosslinked Chitosan Thermosensitive Hydrogel for Injectable Drug Delivery Systems

in vitro and in vivo Morphology and Degradation of Chitosan Based Thermosensitive Hydrogel as Drug Release Matrix

Photo-cross-linked hydrogels from thermoresponsive PEGMEMA-PPGMA-EGDMA copolymers containing multiple methacrylate groups: mechanical property, swelling, protein release, and cytotoxicity.

Tunable Thermo-Responsive Supramolecular Hydrogel: Design, Characterization, and Drug Release

Thermosensitive Chitosan Hydrogel for Implantable Drug Delivery: Blending Pva to Mitigate Body Response and Promote Bioavailability

Preparation of Thermo-Responsive and Injectable Hydrogels Based on Hyaluronic Acid and Poly( N -Isopropylacrylamide) and Their Drug Release Behaviors

Preparation and Drug Release Properties of a Thermo Sensitive GA Hydrogel

Preparation and in Vitro Drug Release of Chitosan-G-mpeg Thermosensitive Hydrogel Drug

Preparation, Thermal Response Mechanisms and Biomedical Applications of Thermosensitive Hydrogels for Drug Delivery

Research Development of In situ Implant Drug Delivery Based on Thermosensitive Hydrogel

[Research progress of methylcellulose-based thermosensitive hydrogels applied in biomedical field]

Effect of poly(ethylene glycol)-derived crosslinkers on the properties of thermosensitive hydrogels

Preparation and Drug-Releasing Properties of Chitosan-Based Thermosensitive Composite Hydrogel

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.

Thermally Responsive Hydrogel Blends: A General Drug Carrier Model for Controlled Drug Release.

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity,<i>in vivo</i>degradation and drug release